相似文献
1
EMA perspective on the value of model-informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding.
CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1820-1823. doi: 10.1002/psp4.13214. Epub 2024 Aug 13.
2
FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use.
J Med Toxicol. 2008 Dec;4(4):284-8. doi: 10.1007/BF03161214.
3
Breast cancer, pregnancy, and breastfeeding.
J Obstet Gynaecol Can. 2002 Feb;24(2):164-80; quiz 181-4.
4
Complementary medicine products information-seeking by pregnant and breastfeeding women in Australia.
Midwifery. 2019 Oct;77:60-70. doi: 10.1016/j.midw.2019.06.011. Epub 2019 Jun 21.
5
Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation.
Br J Clin Pharmacol. 2015 Mar;79(3):537-44. doi: 10.1111/bcp.12515.
6
A Comparison of FDA and EMA Pregnancy and Lactation Labeling.
Clin Pharmacol Ther. 2023 Jun;113(6):1251-1257. doi: 10.1002/cpt.2843. Epub 2023 Feb 5.
7
Delphi survey of international pharmacology experts: an attempt to derive international recommendations for use of medicine in breastfeeding women.
Breastfeed Med. 2015 Apr;10(3):168-74. doi: 10.1089/bfm.2014.0144. Epub 2015 Mar 16.
8
Guideline No. 425b: Cannabis Use Throughout Women's Lifespans - Part 2: Pregnancy, the Postnatal Period, and Breastfeeding.
J Obstet Gynaecol Can. 2022 Apr;44(4):436-444.e1. doi: 10.1016/j.jogc.2022.01.013.
9
A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016).
Value Health. 2019 Feb;22(2):203-209. doi: 10.1016/j.jval.2018.09.2842.
10
Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert.
Int Breastfeed J. 2022 Aug 2;17(1):55. doi: 10.1186/s13006-022-00494-5.
引用本文的文献
1
Pragmatic and contextualized methods selection for safety assessment of infant systemic exposure through human milk: the Milk4baby decision tree approach - a contribution from the concePTION project.
Front Pharmacol. 2025 Aug 5;16:1602018. doi: 10.3389/fphar.2025.1602018. eCollection 2025.
2
PBPK-Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied Population.
CPT Pharmacometrics Syst Pharmacol. 2025 Apr;14(4):738-750. doi: 10.1002/psp4.13311. Epub 2025 Feb 11.
3
Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women.
CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1815-1819. doi: 10.1002/psp4.13269. Epub 2024 Nov 18.
本文引用的文献
1
Drug Utilization Studies in Pregnant Women for Newly Licensed Medicinal Products: A Contribution from IMI ConcePTION.
J Pregnancy. 2024 Jan 11;2024:8862801. doi: 10.1155/2024/8862801. eCollection 2024.
2
Challenges Related to Acquisition of Physiological Data for Physiologically Based Pharmacokinetic (PBPK) Models in Postpartum, Lactating Women and Breastfed Infants-A Contribution from the ConcePTION Project.
Pharmaceutics. 2023 Nov 12;15(11):2618. doi: 10.3390/pharmaceutics15112618.
3
Pharmacokinetic Evaluation in Pregnancy-Current Status and Future Considerations: Workshop Summary.
J Clin Pharmacol. 2023 Jun;63 Suppl 1:S7-S17. doi: 10.1002/jcph.2230.
4
Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.
J Clin Pharmacol. 2023 Jun;63 Suppl 1(Suppl 1):S34-S50. doi: 10.1002/jcph.2227.
5
Addressing drug safety of maternal therapy during breastfeeding using physiologically-based pharmacokinetic modeling.
CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):535-539. doi: 10.1002/psp4.12802. Epub 2022 Apr 28.
6
A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project.
Drug Saf. 2022 Apr;45(4):333-344. doi: 10.1007/s40264-022-01154-7. Epub 2022 Mar 31.
7
Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation.
Front Pediatr. 2021 Jun 23;9:687978. doi: 10.3389/fped.2021.687978. eCollection 2021.
8
PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and Fetus.
AAPS J. 2021 Jun 24;23(4):89. doi: 10.1208/s12248-021-00603-y.
9
Assuring Access to Safe Medicines in Pregnancy and Breastfeeding.
Clin Pharmacol Ther. 2021 Oct;110(4):941-945. doi: 10.1002/cpt.2212. Epub 2021 May 1.
10
A comprehensive review on non-clinical methods to study transfer of medication into breast milk - A contribution from the ConcePTION project.
Biomed Pharmacother. 2021 Apr;136:111038. doi: 10.1016/j.biopha.2020.111038. Epub 2021 Jan 30.
Zotero 插件